Over the past years, most people, when they get GBM, do not not have the temporal/emotional bandwidth, money or resourcefulness to learn about and enter the UK specials program, not to mention most tumors were not saved/stored by freezing. Not to mention NWBO is not allowed to market/advertise until any forthcoming approval.
Upon any approval of DCVax-l, enhanced versions, combinations and currently upgraded manufacturing will expand DCVax’s availability and usefulness to society as trials, programs like the promising pathways act in the U.S. and more approvals hopefully broaden DCVax’s global reach and importance in the war against cancer.
Market Data 
Markets 
AI
